98%
921
2 minutes
20
Temporary pacemakers (TPMs) are usually inserted in an emergency situation. However, there are few reports available regarding which route of access is best or what the most preferred approach is currently in tertiary hospitals. This study aimed to compare procedure times, complication rates, and indications for temporary pacing between the transjugular and transfemoral approaches to TPM placement. We analyzed consecutive patients who underwent TPM placement. Indications; procedure times; and rates of complications including localized infection, any bleeding, and pacing wire repositioning rates were analyzed. A total of 732 patients (361 treated via the transjugular approach and 371 treated via the transfemoral approach) were included. Complete atrioventricular block was the most common cause of TPM placement in both groups, but sick sinus syndrome was especially common in the transjugular approach group. Separately, procedure time was significantly shorter in the transjugular approach group (9.0 ± 8.0 minutes vs. 11.9 ± 9.7 minutes; P < 0.001). Overall complication rates were not significantly different between the two groups, and longer duration of temporary pacing was a risk factor for repositioning. The risk of reposition was significantly increased when the temporary pacing was continued more than 5 days and 3 days in the transjugular approach group and the transfemoral approach group, respectively. The transjugular approach should be considered if the TPM is required for more than 3 days.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217466 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233129 | PLOS |
Am J Gastroenterol
September 2025
Division of Gastroenterology, Department of Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
This guideline presents a comprehensive approach to perioperative risk assessment and management in patients with cirrhosis. Recognizing the unique surgical risks in this population, the guideline emphasizes a multidisciplinary approach to preoperative evaluation, perioperative care, and postoperative follow-up. Key considerations include the severity of liver disease, nonhepatic comorbidities, and surgery-specific factors, with an emphasis on the use of validated cirrhosis-specific risk calculators, such as the VOCAL-Penn Score, for individualized risk stratification.
View Article and Find Full Text PDFJACC Case Rep
August 2025
Interventional Cardiology, Tucson Medical Center, Tucson, Arizona, USA; U.S. Heart and Vascular, Tucson, Arizona, USA.
Background: Percutaneous left atrial appendage closure (LAAC) is an established therapy for stroke prevention in atrial fibrillation patients unable to tolerate long-term oral anticoagulation. Transfemoral access is standard, but may be precluded by chronic venous occlusion, severe iliocaval tortuosity, or other anatomical barriers.
Case Summary: We describe 2 patients with paroxysmal atrial fibrillation, elevated thromboembolic risk, and absolute contraindications to anticoagulation who were unsuitable for transfemoral LAAC due to prohibitive femoral venous anatomy.
Am J Transplant
August 2025
Department of Digestive, Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP Pitié-Salpêtrière Hospital, Paris, France; Sorbonne Université, Paris, France; Centre de Recherche de Saint-Antoine (CRSA), INSERM, UMRS-938, Paris, France. Electronic address:
We report the case of a cirrhotic patient with significant portal hypertension (PHT) who underwent a RAPID procedure (Resection and Partial Liver Segment 2/3 Transplantation with Delayed Total Hepatectomy) using a hyper-small left liver graft with a graft-to-recipient weight ratio (GRWR) of 0.29. To reduce the risk of small-for-size syndrome (SFSS) and modulate portal inflow, a preoperative transjugular intrahepatic portosystemic shunt (TIPS) was placed, decreasing the portosystemic gradient from 15 to 8 mmHg.
View Article and Find Full Text PDFCirc Cardiovasc Interv
August 2025
Center for Structural Heart Disease, Henry Ford Health System, Detroit, MI (J.X.F., P.A.V., T.M.F., L.K.L.L., J.C.L., P.E.G., B.Z., H.A., G.K.F., F.N., T.A., O.A., G.R., W.W.O.N., B.P.O.N.).
Background: The Evoque system is the first commercially available transcatheter tricuspid valve replacement (TTVR) system in the United States. However, challenging anatomy in real-world patients could preclude successful transfemoral Evoque TTVR. We aim to investigate the feasibility of the transjugular Evoque TTVR in anatomy unsuitable for a transfemoral approach.
View Article and Find Full Text PDFChin Med J (Engl)
August 2025
Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Clínic Barcelona, ERN-RareLiver (Health Care Provider of the European Reference Network on Rare Liver Disorders), CSUR Centro de referencia del Sistema Nacional de Salud en Enfermedad Hepática Vascular Compleja en adultos. Ba
The Baveno Cooperation is a consortium of internationally renowned experts committed to setting standards for the clinical management of patients with advanced chronic liver disease, with a particular emphasis on complications related to portal hypertension. Updated every five years and endorsed by major scientific societies, the Baveno recommendations have significantly influenced clinical practice and improved patient outcomes worldwide. The latest Baveno consensus, Baveno VII, provided a series of recommendations that have shifted our understanding of chronic liver disease and portal hypertension and profoundly shaped clinical practice.
View Article and Find Full Text PDF